Skip to main content
Top
Published in: Critical Care 3/2003

Open Access 01-06-2004 | Research

Hyperglycaemic index as a tool to assess glucose control: a retrospective study

Authors: Mathijs Vogelzang, Iwan CC van der Horst, Maarten WN Nijsten

Published in: Critical Care | Issue 3/2003

Login to get access

Abstract

Introduction

Critically ill patients may benefit from strict glucose control. An objective measure of hyperglycaemia for assessing glucose control in acutely ill patients should reflect the magnitude and duration of hyperglycaemia, should be independent of the number of measurements, and should not be falsely lowered by hypoglycaemic values. The time average of glucose values above the normal range meets these requirements.

Methods

A retrospective, single-centre study was performed at a 12-bed surgical intensive care unit. From 1990 through 2001 all patients over 15 years, staying at least 4 days, were included. Admission type, sex, age, Acute Physiology and Chronic Health Evaluation II score and outcome were recorded. The hyperglycaemic index (HGI) was defined as the area under the curve above the upper limit of normal (glucose level 6.0 mmol/l) divided by the total length of stay. HGI, admission glucose, mean morning glucose, mean glucose and maximal glucose were calculated for each patient. The relations between these measures and 30-day mortality were determined.

Results

In 1779 patients with a median stay in the intensive care unit of 10 days, the 30-day mortality was 17%. A total of 65,528 glucose values were analyzed. Median HGI was 0.9 mmol/l (interquartile range 0.3–2.1 mmol/l) in survivors versus 1.8 mmol/l (interquartile range 0.7–3.4 mmol/l) in nonsurvivors (P < 0.001). The area under the receiver operator characteristic curve was 0.64 for HGI, as compared with 0.61 and 0.62 for mean morning glucose and mean glucose. HGI was the only significant glucose measure in binary logistic regression.

Conclusion

HGI exhibited a better relation with outcome than other glucose indices. HGI is a useful measure of glucose control in critically ill patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9CrossRefPubMed
2.
go back to reference Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32: 2426-2432.CrossRefPubMed Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32: 2426-2432.CrossRefPubMed
3.
go back to reference Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87: 978-982. 10.1210/jc.87.3.978CrossRefPubMed Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87: 978-982. 10.1210/jc.87.3.978CrossRefPubMed
4.
go back to reference van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed
5.
go back to reference van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003, 31: 359-366. 10.1097/01.CCM.0000045568.12881.10CrossRefPubMed van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003, 31: 359-366. 10.1097/01.CCM.0000045568.12881.10CrossRefPubMed
6.
go back to reference Fischer KF, Lees JA, Newman JH: Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 1986, 315: 1245-1250.CrossRefPubMed Fischer KF, Lees JA, Newman JH: Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 1986, 315: 1245-1250.CrossRefPubMed
7.
go back to reference Stagnaro-Green A, Barton MK, Linekin PL, Corkery E, deBeer K, Roman SH: Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med 1995, 62: 422-426.PubMed Stagnaro-Green A, Barton MK, Linekin PL, Corkery E, deBeer K, Roman SH: Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med 1995, 62: 422-426.PubMed
8.
go back to reference Brown G, Dodek P: Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med 2001, 29: 1714-1719.CrossRefPubMed Brown G, Dodek P: Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med 2001, 29: 1714-1719.CrossRefPubMed
9.
go back to reference Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J: Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001, 22: 1102-1110. 10.1053/euhj.2000.2445CrossRefPubMed Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J: Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001, 22: 1102-1110. 10.1053/euhj.2000.2445CrossRefPubMed
10.
go back to reference Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, Malmberg K: Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003, 26: 2770-2776.CrossRefPubMed Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, Malmberg K: Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003, 26: 2770-2776.CrossRefPubMed
11.
go back to reference Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG: The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol 1990, 47: 1174-1177.CrossRefPubMed Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG: The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol 1990, 47: 1174-1177.CrossRefPubMed
12.
go back to reference Bolk J, van der PT, Cornel JH, Arnold AE, Sepers J, Umans VA: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001, 79: 207-214. 10.1016/S0167-5273(01)00422-3CrossRefPubMed Bolk J, van der PT, Cornel JH, Arnold AE, Sepers J, Umans VA: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001, 79: 207-214. 10.1016/S0167-5273(01)00422-3CrossRefPubMed
13.
go back to reference Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001, 51: 540-544.CrossRefPubMed Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001, 51: 540-544.CrossRefPubMed
14.
go back to reference Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78: 1471-1478.CrossRefPubMed Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78: 1471-1478.CrossRefPubMed
15.
go back to reference Yendamuri S, Fulda GJ, Tinkoff GH: Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003, 55: 33-38.CrossRefPubMed Yendamuri S, Fulda GJ, Tinkoff GH: Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003, 55: 33-38.CrossRefPubMed
16.
go back to reference Bonnier M, Lonnroth P, Gudbjornsdottir S, Attvall S, Jansson PA: Validation of a glucose-insulin-potassium infusion algorithm in hospitalized diabetic patients. J Intern Med 2003, 253: 189-193. 10.1046/j.1365-2796.2003.01085.xCrossRefPubMed Bonnier M, Lonnroth P, Gudbjornsdottir S, Attvall S, Jansson PA: Validation of a glucose-insulin-potassium infusion algorithm in hospitalized diabetic patients. J Intern Med 2003, 253: 189-193. 10.1046/j.1365-2796.2003.01085.xCrossRefPubMed
17.
go back to reference van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ: Beneficial effect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven [letter]. J Intern Med 2003, 254: 513. 10.1046/j.1365-2796.2003.01190.xCrossRefPubMed van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ: Beneficial effect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven [letter]. J Intern Med 2003, 254: 513. 10.1046/j.1365-2796.2003.01190.xCrossRefPubMed
18.
go back to reference Bonnier M, Lonnroth P, Gudbjornsdottir S, Attvall S, Jansson PA: Beneficial effect of glucose–insulin–potassium infusion in noncritically ill patients has to be proven: reply [letter]. J Intern Med 2003, 254: 514. 10.1046/j.1365-2796.2003.01191.xCrossRef Bonnier M, Lonnroth P, Gudbjornsdottir S, Attvall S, Jansson PA: Beneficial effect of glucose–insulin–potassium infusion in noncritically ill patients has to be proven: reply [letter]. J Intern Med 2003, 254: 514. 10.1046/j.1365-2796.2003.01191.xCrossRef
19.
go back to reference Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003, 290: 2041-2047. 10.1001/jama.290.15.2041CrossRefPubMed Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003, 290: 2041-2047. 10.1001/jama.290.15.2041CrossRefPubMed
20.
go back to reference Pomposelli JJ, Baxter JK III, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998, 22: 77-81.CrossRefPubMed Pomposelli JJ, Baxter JK III, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998, 22: 77-81.CrossRefPubMed
21.
go back to reference Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67: 352-360. 10.1016/S0003-4975(99)00014-4CrossRefPubMed Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67: 352-360. 10.1016/S0003-4975(99)00014-4CrossRefPubMed
22.
go back to reference Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52: 280-284.CrossRefPubMed Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52: 280-284.CrossRefPubMed
23.
go back to reference Dorhout Mees SM, Van Dijk GW, Algra A, Kempink DR, Rinkel GJ: Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003, 61: 1132-1133.CrossRefPubMed Dorhout Mees SM, Van Dijk GW, Algra A, Kempink DR, Rinkel GJ: Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003, 61: 1132-1133.CrossRefPubMed
24.
go back to reference Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD: A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003, 89: 512-516. 10.1136/heart.89.5.512PubMedCentralCrossRefPubMed Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD: A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003, 89: 512-516. 10.1136/heart.89.5.512PubMedCentralCrossRefPubMed
25.
go back to reference Lam AM, Winn HR, Cullen BF, Sundling N: Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991, 75: 545-551.CrossRefPubMed Lam AM, Winn HR, Cullen BF, Sundling N: Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991, 75: 545-551.CrossRefPubMed
26.
go back to reference Paret G, Barzilai A, Lahat E, Feldman Z, Ohad G, Vardi A, Ben Abraham R, Barzilay Z: Gunshot wounds in brains of children: prognostic variables in mortality, course, and outcome. J Neurotrauma 1998, 15: 967-972.CrossRefPubMed Paret G, Barzilai A, Lahat E, Feldman Z, Ohad G, Vardi A, Ben Abraham R, Barzilay Z: Gunshot wounds in brains of children: prognostic variables in mortality, course, and outcome. J Neurotrauma 1998, 15: 967-972.CrossRefPubMed
27.
go back to reference Penney DG: Hyperglycemia exacerbates brain damage in acute severe carbon monoxide poisoning. Med Hypotheses 1988, 27: 241-244. 10.1016/0306-9877(88)90151-XCrossRefPubMed Penney DG: Hyperglycemia exacerbates brain damage in acute severe carbon monoxide poisoning. Med Hypotheses 1988, 27: 241-244. 10.1016/0306-9877(88)90151-XCrossRefPubMed
28.
go back to reference Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000, 46: 335-342. 10.1159/000007307CrossRefPubMed Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000, 46: 335-342. 10.1159/000007307CrossRefPubMed
29.
go back to reference Young B, Ott L, Dempsey R, Haack D, Tibbs P: Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg 1989, 210: 466-472.PubMedCentralCrossRefPubMed Young B, Ott L, Dempsey R, Haack D, Tibbs P: Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg 1989, 210: 466-472.PubMedCentralCrossRefPubMed
30.
go back to reference Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004, 27: 461-467.CrossRefPubMed Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004, 27: 461-467.CrossRefPubMed
31.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710. 10.1007/s001340050156CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710. 10.1007/s001340050156CrossRefPubMed
32.
go back to reference Chee F, Fernando T, van Heerden PV: Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care 2002, 30: 295-307.PubMed Chee F, Fernando T, van Heerden PV: Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care 2002, 30: 295-307.PubMed
33.
go back to reference Chee F, Fernando T, van Heerden PV: Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003, 7: 43-53. 10.1109/TITB.2003.808509CrossRefPubMed Chee F, Fernando T, van Heerden PV: Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003, 7: 43-53. 10.1109/TITB.2003.808509CrossRefPubMed
34.
go back to reference Jungheim K, Wientjes KJ, Heinemann L, Lodwig V, Koschinsky T, Schoonen AJ: Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system. Diabetes Care 2001, 24: 1696-1697.CrossRefPubMed Jungheim K, Wientjes KJ, Heinemann L, Lodwig V, Koschinsky T, Schoonen AJ: Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system. Diabetes Care 2001, 24: 1696-1697.CrossRefPubMed
35.
go back to reference Kapitza C, Lodwig V, Obermaier K, Wientjes KJ, Hoogenberg K, Jungheim K, Heinemann L: Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther 2003, 5: 609-614. 10.1089/152091503322250622CrossRefPubMed Kapitza C, Lodwig V, Obermaier K, Wientjes KJ, Hoogenberg K, Jungheim K, Heinemann L: Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther 2003, 5: 609-614. 10.1089/152091503322250622CrossRefPubMed
Metadata
Title
Hyperglycaemic index as a tool to assess glucose control: a retrospective study
Authors
Mathijs Vogelzang
Iwan CC van der Horst
Maarten WN Nijsten
Publication date
01-06-2004
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2003
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2840

Other articles of this Issue 3/2003

Critical Care 3/2003 Go to the issue